Imikhiqizo efakwe i-CBD Iza Ku-Walgreens naku-CVS Eduze Kwakho

-Delile

• Buyekeza kwe-

I-CBD (i-cannabidiol) ingenye yezindlela ezintsha zokuphila kahle ze-buzziest eziqhubeka nokwanda ekuthandeni. Ngaphezu kokuphakanyiswa njengendlela yokwelapha engaba khona yokulawula izinhlungu, ukukhathazeka, nokunye, inhlanganisela yensangu ibilokhu ikhula kukho konke kusukela ewayinini, ikhofi, nezimonyo, ukuya ocansini nemikhiqizo yesikhathi. Yingakho kungamangazi ukuthi ama-CVS nama-Walgreens azoqala ukuthengisa imikhiqizo efakwe i-CBD ezindaweni ezikhethiwe kulo nyaka.

Phakathi kwamaketanga amabili, izitolo ezingama-2 300 zizosula amashalofu ukwethula okhilimu abafakwe i-CBD, ama-lotion, amapeshi nezipreyi, ezweni lonke, ngokusho Forbes. Okwamanje, ukwethulwa kukhawulelwe ezifundazweni eziyisishiyagalolunye ezigunyaze ukuthengiswa kwensangu, okubandakanya iColorado, Illinois, Indiana, Kentucky, New Mexico, Oregon, Tennessee, South Carolina, kanye neVermont.

Uma uyi-CBD rookie, yazi ukuthi izinto azikuphakamisi phezulu. Kususelwa kuma-cannabinoids ku-cannabis bese kuxutshwa no-oyela othwala, njenge-MCT (uhlobo lwamafutha kakhukhunathi), futhi awunamphumela omubi omubi, ngokusho kweWorld Health Organisation. I-CBD inenkanyezi esegolide evela ku-FDA uma kuziwa ekwelapheni ukuquleka: NgoJanuwari odlule, i-ejensi yagunyaza i-Epidiolex, isixazululo somlomo se-CBD, njengokwelashwa kwezinhlobo ezimbili zesifo sokuwa esibi kakhulu. (Nakhu konke odinga ukukwazi mayelana nomehluko phakathi kwe-CBD, iTHC, insangu, insangu, ne-hemp.)

Njengamanje, awekho ama-Walgreens noma ama-CVS abelane ngqo ngemikhiqizo ye-CBD abazoyengeza kulayini lwabo. Kepha iqiniso lokuthi le mikhiqizo eyaziwa kuzwelonke ibeka isisindo sayo ngemuva kwale mikhiqizo yizindaba ezinhle kubathandi be-CBD yonke indawo-ikakhulukazi uma kuziwa ekuthengeni imikhiqizo ongayethemba.

Njengoba i-CBD iseyintsha emakethe yezempilo, ayilawulwa yi-FDA. Ngamanye amagama, i-ejensi ayiqapheli ngokuqinile ukwenziwa nokusatshalaliswa kwe-CBD, ngakho-ke abakhiqizi abangaphansi kokuhlolisiswa okuqinile uma kukhulunywa ngokuthi bakwenza kanjani, bakulebula futhi bathengise indalo yabo ye-cannabis. Lokhu kushoda komthethonqubo kungashiya umnyango uvulekele abathengisi abazama nje ukwenza imali ngale mikhiqizo ethandwayo ngokukhangisa okungelona kanye / noma okukhohlisayo.

Eqinisweni, ucwaningo olwenziwe yi-FDA luthole ukuthi cishe amaphesenti angama-26 emikhiqizo ye-CBD emakethe aqukethe i-CBD engaphansi kakhulu ngemililitha kunalezo ezisikiselwa amalebula. Futhi ngaphandle kwemithethonqubo emincane, kunzima kubathengi be-CBD ukwethemba noma ukwazi ukuthi bathengani ngempela.

Kodwa manje njengoba i-CVS kanye ne-Walgreens benza imikhiqizo ye-CBD ifinyeleleke nakakhulu, kungase kube khona ukucindezela okukhulu kohlaka olusha lokulawula. Isakhiwo esisha nesicociwe ngethemba sizohlinzeka ngeziqondiso ezibambekayo zalokho amabhrendi e-CBD angakwazi-futhi okubaluleke nakakhulu-angeke akwazi ukukwenza ngaphambi kokubeka imikhiqizo yawo emakethe. Empeleni, kuningi okusamele sikwenze, kepha lezi zindaba zisiletha igxathu elilodwa ekwenzeni ukuthenga kwe-CBD kuphephe futhi kuthembeke kuwo wonke umuntu.

Buyekeza kwe-